These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32796817)

  • 1. MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.
    Bao C; Chen J; Chen D; Lu Y; Lou W; Ding B; Xu L; Fan W
    Cell Death Dis; 2020 Aug; 11(8):618. PubMed ID: 32796817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
    Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
    J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1.
    Xia L; Li F; Qiu J; Feng Z; Xu Z; Chen Z; Sun J
    BMC Cancer; 2020 Oct; 20(1):949. PubMed ID: 33008330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
    Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
    Rasoolnezhad M; Safaralizadeh R; Hosseinpour Feizi MA; Banan-Khojasteh SM; Roshani Asl E; Lotfinejad P; Baradaran B
    Mol Biol Rep; 2023 Oct; 50(10):8407-8420. PubMed ID: 37620737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
    Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J
    Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.
    Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB
    Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1.
    Zhao Y; Jin LJ; Zhang XY
    Aging (Albany NY); 2021 Jul; 13(14):18498-18514. PubMed ID: 34292880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
    Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL
    Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.
    Irani S; Paknejad M; Soleimani M; Azam S
    Iran Biomed J; 2020 Nov; 24(6):361-9. PubMed ID: 32660221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1-pRB-E2F1 pathway.
    Wang J; Zhang J; Ma Q; Zhang S; Ma F; Su W; Zhang T; Xie X; Di C
    J Cell Mol Med; 2023 Apr; 27(7):991-1005. PubMed ID: 36915230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells.
    Zhang K; Dai L; Zhang B; Xu X; Shi J; Fu L; Chen X; Li J; Bai Y
    J Cell Physiol; 2015 Apr; 230(4):903-10. PubMed ID: 25216463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
    J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
    Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
    J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-490-5P Targets CCND1 to Suppress Cellular Proliferation in Glioma Cells and Tissue Through Cell Cycle Arrest.
    Zhao L; Tang X; Luo R; Duan J; Wang Y; Yang B
    Curr Neurovasc Res; 2018; 15(3):246-255. PubMed ID: 30101705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-1258 Regulates Cell Proliferation and Cell Cycle to Inhibit the Progression of Breast Cancer by Targeting E2F1.
    Zhao X
    Biomed Res Int; 2020; 2020():1480819. PubMed ID: 32733928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Ofir M; Hacohen D; Ginsberg D
    Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.